Dimethylformamide → tert-butyl 2-((4R,6S)-6-((E)-2-(4-(4-fluorophenyl)-6-isopropyl-2-(N-methylmethylsulfonamido)pyrimidin-5-yl)vinyl)-2,2-dimethyl-1,3-dioxan-4-yl)acetate

HRID 1663307ノート

反応式

HRID 1663307 の反応式
Br[C:2]1[C:3]([C:17]2[CH:22]=[CH:21][C:20]([F:23])=[CH:19][CH:18]=2)=[N:4][C:5]([N:11]([CH3:16])[S:12]([CH3:15])(=[O:14])=[O:13])=[N:6][C:7]=1[CH:8]([CH3:10])[CH3:9].[CH3:24][C:25]1([CH3:41])[O:30][C@@H:29]([CH2:31][C:32]([O:34][C:35]([CH3:38])([CH3:37])[CH3:36])=[O:33])[CH2:28][C@@H:27]([CH:39]=[CH2:40])[O:26]1.C1(CNCC2CCCCC2)CCCCC1.CN(C)C=O>C(OCC)(=O)C.O.C(O)(=O)C>[F:23][C:20]1[CH:21]=[CH:22][C:17]([C:3]2[C:2](/[CH:40]=[CH:39]/[C@H:27]3[O:26][C:25]([CH3:24])([CH3:41])[O:30][C@@H:29]([CH2:31][C:32]([O:34][C:35]([CH3:38])([CH3:37])[CH3:36])=[O:33])[CH2:28]3)=[C:7]([CH:8]([CH3:10])[CH3:9])[N:6]=[C:5]([N:11]([CH3:16])[S:12]([CH3:15])(=[O:14])=[O:13])[N:4]=2)=[CH:18][CH:19]=1

参加物

8

反応条件

温度
50 °C

実験手順

A mixture of N-(5-bromo-4-(4-fluorophenyl)-6-isopropylpyrimidin-2-yl)-N-methylmethanesulfonamide (1.00 g, 2.50 mmol), bis-tri-tert-butylphosphine palladium (0) (131 mg, 0.250 mmol), tert-butyl 2-((4R,6S)-2,2-dimethyl-6-vinyl-1,3-dioxan-4-yl)acetate (640 mg, 2.50 mmol), water (5 mL), N,N-dicyclohexylmethylamine (0.530 mL, 2.50 mmol), and N,N-dimethylformamide (5 mL) was heated and stirred at 50° C. under nitrogen for four days. The mixture was then diluted with ethyl acetate (11 mL), water (10 mL), and acetic acid (0.2 mL). The organic phase was separated and the aqueous phase was extracted with ethyl acetate (5 mL). The combined organic phases were washed with water (10 mL), then brine (10 mL), and concentrated in vacuo to give a yellow oil containing some solids. This material was adsorbed onto silica gel through dissolution in ethyl acetate, then purified by flash chromatography (5% ethyl acetate in isohexane gradually increasing to 20% ethyl acetate in hexane, silica column 25 mm in diameter and 250 mm in height) to yield tert-butyl 2-((4R,6S)-6-((E)-2-(4-(4-fluorophenyl)-6-isopropyl-2-(N-methylmethanesulfonamido)pyrimidin-5-yl)vinyl)-2,2-dimethyl-1,3-dioxan-4-yl)acetate of the formula

後処理

  1. temperaturewas heated
  2. customThe organic phase was separated
  3. extractionthe aqueous phase was extracted with ethyl acetate (5 mL)
  4. washThe combined organic phases were washed with water (10 mL)
  5. concentrationbrine (10 mL), and concentrated in vacuo
  6. customto give a yellow oil
  7. additioncontaining some solids
  8. custompurified by flash chromatography (5% ethyl acetate in isohexane
  9. temperaturegradually increasing to 20% ethyl acetate in hexane, silica column 25 mm in diameter and 250 mm in height)

出典と根拠

ORDレコード
ord-b4ef65ee28e84db0a8587c4fe9643027
出典データセット
uspto-grants-2011_10
特許番号
US08034932B2

反応ノート

読み込み中…